Newsfeeds - Spark Newswire

2 minute read

Events
News

Surrozen Presented Data Supporting Potential Of SZN-1326 At The 2021 United European Gastroenterology Week

Today, 8:32 PM

Surrozen, Inc. (NASDAQ:SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, announced today that data from its inflammatory bowel disease (IBD)

SRZN

4 minute read

50 Biggest Movers From Yesterday

By Lisa Levin

Today, 8:32 PM

Gainers

AGMH

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

Today, 8:32 PM

Gainers

CRVS

6 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 15, 2021

By Benzinga Insights

Today, 8:32 PM

1 minute read

Guggenheim Initiates Coverage On Surrozen with Buy Rating, Announces Price Target of $20

By Benzinga Newsdesk

Today, 8:32 PM

Guggenheim analyst Yatin Suneja initiates coverage on Surrozen (NASDAQ:SRZN) with a Buy rating and announces Price Target of $20.

SRZN

4 minute read

The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs

By Shanthi Rexaline

Today, 8:32 PM

Biotech stocks retreated in the holiday-shortened week ending Sept. 10, reversing course from the previous week.

ALRN

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 8:32 PM

Gainers

BYSI

5 minute read

The Daily Biotech Pulse: MacroGenics’ Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA’s FDA Nod

By Shanthi Rexaline

Today, 8:32 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7)

ADIL

6 minute read

72 Biggest Movers From Yesterday

By Lisa Levin

Today, 8:32 PM

Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth.

ABOS

2 minute read

Mid-Afternoon Market Update: Dow Falls Over 200 Points; RenovoRx Shares Spike Higher

By Lisa Levin

Today, 8:32 PM

Toward the end of trading Tuesday, the Dow traded down 0.65% to 35,138.64 while the NASDAQ rose 0.13% to 15,383.18. The S&P also fell, dropping 0.27% to 4,522.99.

ADAP